Skip to search formSkip to main contentSkip to account menu

Acute Myeloid Leukemia in Remission

Known as: Acute Myeloblastic Leukemia in Remission, Acute Granulocytic Leukemia in Remission, Acute myeloid leukemia, in remission 
Acute myeloid leukemia not growing, responding to treatment.
National Institutes of Health

Related topics

Related topics

4 relations
Hematopoietic and Lymphoid CellHematopoietic and Lymphoid TissueHemopoietic tissueLeukemia, Myelocytic, Acute

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Results of a Phase 1 Study of Quizartinib (AC220) As Maintenance Therapy in Subjects with Acute Myeloid Leukemia in Remission Following Allogeneic Hematopoietic Cell Transplantation
FMS-like tyrosine kinase 3 internal tandem duplications (FLT3-ITD) in acute myeloid leukemia (AML) are associated with early… 
1997
1997
Prognostic value of metaphase-fluorescence in situ hybridization in follow-up of patients with acute myeloid leukemia in remission.
The presence of residual leukemic cells was studied using metaphase-fluorescence in situ hybridization (FISH) in 22 patients with… 
1988
1988
High‐dose retinol in children with acute myelogenous leukemia in remission
In a single‐institution study, 23 consecutive children with acute myeloid leukemia (AML) have been treated with a protocol… 
Highly Cited
1987
Highly Cited
1987
Intensive remission consolidation therapy in the treatment of acute nonlymphocytic leukemia.
A pilot study was conducted to determine the possible efficacy and the toxicities associated with the administration of four… 
1987
1987
Graft-versus-leukemia in man: relationship of acute and chronic graft-versus-host disease to relapse of acute leukemia following allogeneic bone marrow transplantation.
To study the effect of acute and chronic graft-versus-host disease (GVHD) on recurrent leukemia, we analysed data on patients… 
1984
1984
Deficiency of erythrocyte superoxide dismutase and catalase activities in patients with malignant lymphoma and acute myeloid leukemia.
1983
1983
Development of a cell kinetic approach to curative therapy of acute myelocytic leukemia in remission using the cell cycle-specific drug 1-beta-D-arabinofuranosylcytosine in a rat model.
The timing of sequentially administered antineoplastic drugs is one determinant of toxicity and therapeutic benefit. We have… 
Highly Cited
1982
Highly Cited
1982
A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
1-beta-D-Arabinofuranosylcytosine (ara-C), 2 or 3 g/sq m, was administered as a 1-hr i.v. infusion every 12 hr for 10 or 12 doses… 
1982
1982
Enrichment and cryopreservation of bone marrow progenitor cells for autologous reinfusion.
Review
1977
Review
1977
Granulocytic sarcoma of the brain
An unusual case of granulocytic sarcoma (chloroma) of the parenchyma of the brain occurring in a patient with acute myelocytic… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)